ArGEN-X to discover Abs for Bayer using llama tech
ArGEN-X, best known for its clinical development work, has announced it will help Bayer develop antibodies for complex disease targets.
Archives for May 27, 2014
Biopharma wary of disposable systems for large-scale production... for now
Janssen has mirrored Pfizer’s concerns about the scale, price and robustness of using single-use technology for high-volume production but says industry collaboration could help bring standards in place.
Researchers look to unveil why mAbs can be difficult to administer
Potentially valuable monoclonal antibodies (mAbs) may find difficulties with administration due to high viscosity, though researchers are now turning to neutron spin echo instruments to gain a better understanding of what is occurring, according to new...